Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn’t yet been ap ...

Novo Nordisk faces scrutiny over UK pharmacy sponsorships tied to weight-loss drugs, with critics citing conflicts of interest and regulatory breaches.

Heavy drinkers who were ­taking weight-loss jabs in a Dublin clinic significantly reduced their ­alcohol intake down from 12 ...

However, a third drug also FDA-approved for weight loss, liraglutide (Saxenda), didn’t work as ... Each of those drugs are taken once a week, by an injection. By comparison, the FDA-approved ...

including Wegovy and Saxenda, on social media. Posts by the clinics featured images of weight-loss injection pens and direct references to the drugs, violating UK advertising rules. Novo Nordisk ...